Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings
Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when the pharmaceutical company’s net sales grew by 14%.
Worldwide sales rose 14% year-over-year to $14.9 billion during the quarter. Pharmaceutical sales grew 13%, which was partially offset by a 3% sales drop in the animal health segment.
Third-quarter earnings, on an adjusted basis, moved up to $1.85 per share from $1.78 per share in the same quarter of 2021. Unadjusted net income was $3.25 billion or $1.28 per share in the most recent quarter, compared to $4.57 billion or $1.80 per share in the corresponding period of the previous year.
Check this space to read management/analysts’ comments on Merck’s Q3 2022 earnings report
“Our third quarter results demonstrate exceptional revenue and underlying earnings growth and sustained performance across our key growth drivers. Inspired by our purpose of saving and improving lives around the world, I am confident we are well-positioned to continue to deliver strong operational performance,” said Robert Davis, chief executive officer of Merck.
Prior Performance
Most Popular
AAPL Earnings: Apple’s Q2 sales and profit beat estimates; iPhone sales down 10%
Apple Inc. (NASDAQ: AAPL) on Thursday reported better-than-expected profit and revenue for the second quarter of 2024. There was a 10% decrease in iPhone sales. The gadget giant reported revenues
Shopify (SHOP) is all set to report Q1 2024 results. Here’s what to expect
Over the years, Shopify Inc. (NYSE: SHOP) has steadily expanded its footprint in the online retail market through constant innovation, like the recent launch of a mobile POS device for
eBay (EBAY): A look at how the ecommerce company fared in Q1 2024
Shares of eBay Inc. (NASDAQ: EBAY) were down over 2% on Thursday. The company reported its earnings results for the first quarter of 2024 a day ago, with revenue and